|

venetoclax combining chidamide and azacitidine (VCA) Clinical Trials

1 actively recruiting trial

Also known as: VCA

Pipeline

Phase 2: 1

Top Sponsors

  • The First Affiliated Hospital of Xiamen University1

Indications

  • Relapsed Adult AML1
  • Refractory Leukemia1
  • Leukemia, Myeloid, Acute1
  • Cancer1

Other1 trial

Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.